The medical and scientific teams will work in unison and for each defined ‘leading collaborative project’ a “Principal Investigator” (PI) will be appointed to be responsible for the co-ordination, direction, oversight and the supervision of the particular defined project until its termination.


All procedures will be approved medically and ethically by the corresponding agencies (AGES, EMA, FDA) and Ethic Boards.


The PACT will agree an IP policy in relation to its activities in accordance with the individual Code of Practices or Policies of all partners and national and international guidelines.


The PACT will comply with all the regulations and guidelines specifically within aspects of ethical and legal considerations and issues.